Anupam Raina | Skin Aging Biomarkers and Assessment | Innovative Research Award

Best Researcher Award

Anupam Raina
University of Alabama at Birmingham
Researcher Information
Affiliation University of Alabama at Birmingham
Country United States
Scopus ID 57203243862
Documents 5
Citations 118
h-index 4
Subject Area Skin Aging Biomarkers and Assessment
Event World Skincare Innovation Awards
ORCID 0000-0001-9995-9219

Anupam Raina is a researcher affiliated with the University of Alabama at Birmingham whose scholarly activities contribute to the field of skin aging biomarkers and assessment methodologies. His published work explores biological mechanisms, molecular indicators, and translational approaches relevant to dermatological science and age-related skin changes. Research metrics available through academic indexing databases indicate measurable scholarly impact through publications, citations, and interdisciplinary engagement within biomedical and skincare-related research domains.[1]

Abstract

This article presents an overview of the academic profile and research contributions of Anupam Raina, focusing on investigations related to skin aging biomarkers and assessment strategies. The review highlights publication output, citation performance, research themes, and scholarly relevance within contemporary dermatological and translational biomedical research.[1]

Keywords

  • Skin Aging
  • Biomarkers
  • Dermatology Research
  • Translational Medicine
  • Research Assessment
  • Skincare Innovation

Introduction

The identification and validation of biomarkers associated with skin aging have become important areas of investigation in modern dermatological science. Researchers working in this field contribute to understanding molecular pathways, physiological changes, and clinical assessment methods that support evidence-based skincare innovation and therapeutic development.[2]

Research Profile

Anupam Raina's academic profile demonstrates engagement with biomedical and dermatological research topics, particularly those connected with aging-related biological processes. According to indexed author metrics, the researcher has produced five documented publications and accumulated more than one hundred citations, reflecting scholarly visibility within relevant scientific communities.[1]

Research Contributions

  • Investigation of biological markers associated with skin aging.
  • Assessment methodologies for dermatological evaluation.
  • Contribution to translational approaches linking laboratory findings with clinical applications.
  • Participation in interdisciplinary biomedical research initiatives.
  • Support for evidence-based skincare innovation through scientific investigation.

Publications

The publication record indexed under the researcher's Scopus profile includes studies related to dermatology, aging biology, biomarker discovery, and associated biomedical disciplines. These works collectively contribute to the growing evidence base supporting objective assessment of skin health and age-related physiological changes.[3]

Research Impact

Research impact may be evaluated through publication output, citation performance, and knowledge dissemination. With an h-index of 4 and 118 citations, Anupam Raina's scholarly contributions have received measurable recognition from the academic community. These indicators suggest that the published work has informed subsequent studies and contributed to ongoing scientific discussions within related fields.[1]

Award Suitability

Based on available academic metrics, publication activity, and subject-area specialization, Anupam Raina demonstrates characteristics commonly evaluated in research recognition programs. Contributions related to skin aging biomarkers and assessment align with themes promoted by international scientific forums and innovation-focused award initiatives in skincare and dermatological research.[4]

Conclusion

Anupam Raina's research profile reflects sustained engagement in skin aging and biomarker-related investigations. Through publication activity, citation impact, and scientific contributions relevant to dermatology and skincare innovation, the researcher has established a measurable academic presence. Such achievements provide a foundation for consideration within professional research recognition and award programs.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Anupam Raina, Author ID 57203243862. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57203243862
  2. World Health Organization. (n.d.). Healthy ageing and biological ageing research.
    https://www.who.int/
  3. López-Otín, C., et al. (2013). The Hallmarks of Aging. Cell.
    DOI: 10.1016/j.cell.2013.05.039
    https://doi.org/10.1016/j.cell.2013.05.039
  4. World Skincare Innovation Awards. (n.d.). Award evaluation and recognition framework.
    https://skincareaward.com/
  5. Jylhävä, J., Pedersen, N. L., & Hägg, S. (2017). Biological Age Predictors. EBioMedicine.
    DOI: 10.1016/j.ebiom.2017.03.046
    https://doi.org/10.1016/j.ebiom.2017.03.046

Gordon Bae | Atopic Dermatitis and Eczema Management | Innovative Research Award

Innovative Research Award

Gordon Bae
Stanford University School of Medicine
Researcher Information
Affiliation Stanford University School of Medicine
Country United States
Scopus ID 57072867400
Documents 62
Citations 588
h-index 10
Subject Area Atopic Dermatitis and Eczema Management
Event World Skincare Innovation Awards
ORCID 0009-0003-7168-7049

Gordon Bae is a researcher affiliated with Stanford University School of Medicine whose scholarly activities have contributed to advancing knowledge in atopic dermatitis and eczema management. Through peer-reviewed publications, interdisciplinary collaborations, and evidence-based investigations, the researcher has participated in efforts aimed at improving understanding of inflammatory skin diseases and their clinical management.[1] The body of work associated with this research profile reflects engagement with contemporary dermatological challenges and emphasizes the translation of scientific findings into practical healthcare applications.[2]

Abstract

This article presents an overview of the academic profile and scientific contributions of Gordon Bae in the field of dermatological research, with particular emphasis on atopic dermatitis and eczema management. The profile demonstrates sustained scholarly activity reflected through peer-reviewed publications, citation performance, and collaborative research efforts. These contributions support the continued development of evidence-based approaches for skin health and patient-centered dermatological care.[1]

Keywords

Atopic Dermatitis, Eczema Management, Dermatology, Clinical Research, Skin Health, Evidence-Based Medicine, Inflammatory Skin Disorders, Translational Research.

Introduction

Atopic dermatitis and eczema remain significant global dermatological concerns due to their prevalence, chronicity, and impact on quality of life. Research in this area seeks to improve disease understanding, optimize therapeutic interventions, and enhance long-term patient outcomes. Gordon Bae's scholarly activities contribute to this evolving field through scientific investigation and dissemination of findings within the academic community.[3]

Research Profile

The research profile reflects publication of 62 indexed documents with a citation count of 588 and an h-index of 10. These indicators demonstrate measurable scholarly engagement and visibility within the scientific literature. The research portfolio primarily focuses on dermatological science, inflammatory skin disorders, and clinical aspects of eczema management.[1]

Research Contributions

  • Investigation of clinical and therapeutic aspects of atopic dermatitis.
  • Contribution to evidence-based management strategies for eczema.
  • Participation in collaborative dermatological research initiatives.
  • Publication of findings supporting improved patient care and treatment evaluation.

Publications

Selected publications associated with dermatological research and skin disease management contribute to the scientific literature addressing inflammatory skin disorders and treatment outcomes.[4]

  • Clinical studies related to eczema management and patient outcomes.
  • Research articles exploring inflammatory skin disease mechanisms.
  • Collaborative publications in dermatology and translational medicine.

Research Impact

The citation record and publication activity indicate that the research outputs have attracted attention within the scientific community. Citation-based metrics provide evidence of scholarly influence and suggest that published findings have contributed to ongoing discussions concerning dermatological treatment approaches and disease management strategies.[1][5]

Award Suitability

Based on the available scholarly indicators, publication record, and contributions to dermatological science, Gordon Bae demonstrates characteristics consistent with consideration for recognition within the World Skincare Innovation Awards. The research profile reflects ongoing engagement with scientific advancement, evidence generation, and the promotion of improved understanding of atopic dermatitis and eczema management.[1][2]

Conclusion

Gordon Bae's academic profile highlights meaningful participation in dermatological research and scholarly communication. Through contributions to the study of atopic dermatitis and eczema management, the researcher has supported scientific inquiry and the dissemination of knowledge relevant to skin health. The documented research outputs and citation performance provide evidence of continuing academic engagement and professional impact.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Gordon Bae, Author ID 57072867400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57072867400
  2. ORCID. (n.d.). Gordon Bae researcher profile.
    https://orcid.org/0009-0003-7168-7049
  3. Bae, G., et al. Dermatology and inflammatory skin disease research. DOI Reference.
    https://doi.org/10.1111/all.15789
  4. Academic publication records indexed through scholarly databases relating to eczema and atopic dermatitis management.
    https://www.scopus.com
  5. World Skincare Innovation Awards. Research recognition and evaluation framework.
    https://skincareaward.com/

Alicja C Gluszko| Cell Signaling in Skin| Research Excellence Award

Dr. Alicja C Gluszko| Cell Signalling in Skin| Research Excellence Award

ASST Professor | Medical University Of Warsaw | Poland

Alicja Głuszko is a researcher specializing in biomedical sciences, with a focus on molecular mechanisms underlying disease progression and therapeutic innovation. Her research centers on cellular signaling pathways, inflammation, and translational strategies aimed at improving clinical outcomes. She has contributed to advancing knowledge in pathophysiology through interdisciplinary approaches integrating experimental and clinical insights. Affiliated with the Medical University of Warsaw, she has held key academic research roles, collaborating across international scientific networks. Her work has resulted in impactful peer-reviewed publications and contributions to emerging therapeutic frameworks. Głuszko’s research has significantly enhanced understanding of disease biomarkers and targeted interventions. Her vision is to bridge fundamental science with clinical application, fostering innovations that benefit patient care and public health. She aims to contribute to global scientific progress by developing evidence-based solutions that address complex medical challenges and support sustainable healthcare advancements.

Citation Metrics (Google Scholar)

1000

500

100

0

Citations
515

Documents
11

h-index
11

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar
View Scopus Profile View Orchid Profile

Featured Publications

Ju-Seop Kang | Skin barrier function | Best Researcher Award

Dr. Ju-Seop Kang | Skin Barrier Function | Best Researcher Award

Professor | Hanyang University| South Korea

Dr. Ju-Seop Kang is a distinguished researcher specializing in skin barrier function, with interdisciplinary expertise spanning biomedical science, bioengineering, and clinical therapeutics. His research focuses on understanding the mechanisms regulating skin integrity, plasma-activated biomedical technologies, and advanced biosensor systems for diagnostic and therapeutic applications. He actively explores emerging innovations in translational medicine, integrating computational modeling with experimental validation to enhance clinical relevance. Dr. Kang serves at Hanyang University College of Medicine, where he contributes to cutting-edge research and collaborative scientific initiatives. His key contributions include advancements in plasma-activated water technologies, development of high-performance biosensors, and innovative therapeutic strategies addressing skin and systemic conditions. With a publication record reflecting growing impact, he has one publication with three citations and an h-index of 1. His vision is to advance skin health science through scalable biomedical innovations, contributing to improved clinical treatments, global healthcare solutions, and next-generation diagnostic technologies.

Citation Metrics (Scopus)

3000

500

100

0

Citations
2,631

Documents
94

h-index
24

🟦 Citations
🟥 Documents
🟩 h-index

View Scopus Profile View Google Scholar

Featured Publications

Claudio Villota Arcos | Skin Aging | Research Excellence Award

Dr. Claudio Villota Arcos | Skin Aging | Research Excellence Award

Investigador | Universidad Bernardo O'Higgins | Chile 

Dr. Claudio Villota Arcos is a researcher specializing in cellular and molecular biology, with a strong interdisciplinary focus on cancer biology, mitochondrial genetics, virology, and nutrition-related molecular mechanisms. His research centers on the role of mitochondrial non-coding RNAs in cancer initiation, progression, and therapeutic targeting, alongside emerging interests in viral oncogenesis, metabolic regulation, and inflammation-linked diseases. Dr. Villota Arcos serves as an academic researcher at the School of Nutrition and Dietetics, Universidad Bernardo O’Higgins, where he integrates molecular biology with translational health research. His key contributions include pioneering discoveries on antisense mitochondrial non-coding RNAs as selective vulnerabilities in cancer cells, advancing novel molecular targets for cancer therapy, and influencing diagnostic and therapeutic research strategies. His impact vision emphasizes translating fundamental mitochondrial biology into clinically relevant innovations, strengthening precision oncology approaches, and bridging molecular science with public health and nutritional interventions for global disease prevention.

Citation Metrics (Scopus)

700

400

50

0

Citations
662

Documents
26

h-index
12

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar
View Scopus profile View ORCID profile

Featured Publications


Expression of a family of noncoding mitochondrial RNAs

– Proceedings of the National Academy of Sciences,, 2009

Down-regulation of antisense mitochondrial non-coding

–. Journal of Biological Chemistry, 2014

Reinhard Heinz Hans Neubert | Dermatopharmacy | Distinguished Scientist Award

Prof. Reinhard Heinz Hans Neubert | Dermatopharmacy | Distinguished Scientist Award

Vice-Chairman  | Matin Luther University | Germany

Prof. Dr.Reinhard Heinz Hans Neubert is a leading researcher specializing in dermal drug delivery and dermatopharmaceutical sciences, currently affiliated with the Institute of Applied Dermatopharmacy (IADP), Martin Luther University Halle-Wittenberg. His research focuses on dermal and transdermal drug delivery systems, nanostructure and organization of stratum corneum lipids, ceramide chemistry, colloidal carrier systems, phytopharmaceuticals, and the application of affinity capillary electrophoresis to optimize topical formulations. With extensive academic and translational experience, he has led large-scale collaborative research initiatives and advised numerous postgraduate researchers while also contributing to industry-oriented innovation through consultancy and technology transfer. His key contributions include pioneering insights into skin barrier lipid organization, advancement of analytical methods for skin penetration studies, and the development of innovative dermal delivery platforms supported by multiple patents. Impact Vision: Prof. Neubert’s work strengthens the scientific foundation of skin barrier research and accelerates the translation of dermatological innovations into effective, safe, and globally relevant therapeutic and cosmetic solutions.

Citation Metrics (Scopus)

14000

1000

600

500

0

Citations
13,603

Documents
474

h-index
56

🟦 Citations
🟥 Documents
🟩 h-index


View Scopus Profile
View ORCID profile

Featured Publications


Potentials of new nanocarriers for dermal and transdermal drug delivery

–European Journal of Pharmaceutics and Biopharmaceutics, , 2011

Ceramides and barrier function of the skin

– Skin Pharmacology and Physiology, 2015

Affinity capillary electrophoresis as a tool for optimizing topical drug formulations

– Journal of Pharmaceutical and Biomedical Analysis,2019

Panagiotis Halvatsiotis | Skin Health | Research Excellence Award 

Prof. Panagiotis Halvatsiotis | Skin Health | Research Excellence Award 

Researcher | University of Athens | Greece

Panagiotis Halvatsiotis is an Assistant Professor of Medicine with specialization in endocrinology and metabolic research, focusing on diabetes, obesity, insulin resistance, and metabolic regulation across clinical and molecular contexts. His research explores skeletal muscle metabolism, protein synthesis, adipokine signaling, and the metabolic impact of nutritional and pharmacological interventions, alongside emerging interests in population-based metabolic risk and COVID-19–related metabolic outcomes. He holds key academic and clinical research roles within university medical settings and has collaborated extensively in multidisciplinary, international research teams. Dr. Halvatsiotis has made significant contributions through high-impact studies elucidating insulin action, amino acid kinetics, and metabolic dysregulation in type 2 diabetes, as well as influential systematic reviews informing dietary and public health policy. His work has generated widely cited evidence shaping clinical practice guidelines. His impact vision centers on translating metabolic research into scalable interventions that improve chronic disease management, inform evidence-based nutrition strategies, and advance global metabolic health innovation.

Citation Metrics (Google Scholar)

1500

1000

600

0

Citations
1455

Documents
17

h-index
28

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar

Featured Publications

Meheli Ghosh | Dermatology | Research Excellence Award

Meheli Ghosh | Dermatology | Research Excellence Award

PHD | Mercer University | United States

Meheli Ghosh is a pharmaceutical sciences researcher specializing in advanced drug delivery systems and dermatological/transdermal formulation development. Her research focuses on topical and transdermal drug delivery, microneedle-based systems, nanoparticulate and microparticulate carriers, foam and gel formulations, and quality-by-design approaches for skin-targeted therapies, with emerging interests in regulatory-relevant bioequivalence and late-stage product development. She has gained significant research experience through collaborative projects with the U.S. Food and Drug Administration, NIH-funded programs, and industry-aligned research at Merck Group, contributing to formulation design, process optimization, IVRT/IVPT studies, and regulatory documentation. Her key contributions include the development of novel drug-loaded microneedles using vacuum compression molding, innovative nanoparticle- and emulsome-based systems for chemical injury mitigation, and advanced topical platforms addressing unmet dermatological needs. Impact Vision: Her work bridges academic research and regulatory science, accelerating the translation of safe, effective, and scalable dermatological therapies that advance global skin health and pharmaceutical innovation.

 

Citation Metrics (Google Scholar)

100

80

60

20

0

Citations
94

i10-index
4

h-index
4

🟦 Citations
🟥 i10-index
🟩 h-index


View Google Scholar

Featured Publications

 

Claudia Botelho | Skin Regeneration | Editorial Board Member

Dr. Claudia Botelho | Skin Regeneration | Editorial Board Member

Researcher | Universidade do Porto | Portugal

Dr. C. M. Botelho, a senior researcher at the Universidade do Porto, Portugal, is a highly accomplished scientist whose work spans natural products chemistry, bioactive compounds, sustainable biomaterials, cosmetic formulation science, and microfluidic technologies. With advanced academic training in pharmaceutical sciences and bioactive natural products, Dr. Botelho has built a distinguished career centered on the chemical characterization, extraction, and application of plant-derived antioxidants, anti-inflammatory agents, and nutraceutical components. Over the years, Dr. Botelho has authored 70 peer-reviewed scientific publications, which have collectively accumulated over 2,061 citations and contributed to an impressive h-index of 25, demonstrating significant international influence and sustained scientific productivity. Her recent works include cutting-edge studies on microfluidic flow-focusing for cubosome formation, phenolic profiling of medicinal plants, sustainable recovery of olive-oil by-products, and the development of cosmetic creams enriched with grape stem extracts, highlighting her leadership in combining sustainability, biotechnology, and human health research. Additional notable contributions include investigations into anti-inflammatory phytochemicals, bioactive potential of grape stem blends for skin regeneration, and microwave-assisted extraction of raspberry pomace, advancing both food science and dermatological innovation. Dr. Botelho has collaborated with more than 240 co-authors from multidisciplinary fields, reflecting her strong international research network and ability to drive collaborative scientific advancements. Her scholarship not only contributes to greener industrial practices but also supports the development of innovative cosmetic, pharmaceutical, and nutraceutical products with societal and commercial impact. In addition to research excellence, Dr. Botelho actively contributes to the scientific community through peer-review service and involvement with international journals in natural products and pharmaceutical sciences. Her continued work positions her as a key contributor to sustainable bioproduct development and the future of functional plant-based innovations.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

1. Silva-Fernandes, A., Costa, M. D. C., Duarte-Silva, S., Oliveira, P., … Botelho, C. M. (2010). Motor uncoordination and neuropathology in a transgenic mouse model of Machado–Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products. Neurobiology of Disease.

2. Botelho, C. M., Brooks, R. A., Spence, G., McFarlane, I., Lopes, M. A., Best, S. M., … (2006). Differentiation of mononuclear precursors into osteoclasts on the surface of Si‐substituted hydroxyapatite. Journal of Biomedical Materials Research Part A.

3. Oliveira, C., Coelho, C., Teixeira, J. A., Ferreira-Santos, P., & Botelho, C. M. (2022). Nanocarriers as active ingredients enhancers in the cosmetic industry: The European and North America regulation challenges. Molecules.

4. Fernandes, M., Lopes, I., Magalhães, L., Sárria, M. P., Machado, R., Sousa, J. C., … (2021). Novel concept of exosome-like liposomes for the treatment of Alzheimer’s disease. Journal of Controlled Release.

5. Oliveira, C., Sousa, D., Teixeira, J. A., Ferreira-Santos, P., & Botelho, C. M. (2023). Polymeric biomaterials for wound healing. Frontiers in Bioengineering and Biotechnology.

Mohammad Hossein Ahmadi | Skin inflammation | Editorial Board Member

Prof. Mohammad Hossein Ahmadi | Skin inflammation | Editorial Board Member

Associate Professor of Medical Bacteriology | Shahed University | Iran

Dr. Mohammad Hossein Ahmadi, a distinguished researcher at Shahed University, Tehran, Iran, is recognized for his impactful contributions to microbiology, infectious diseases, and biomedical sciences. He holds advanced academic training in biological and medical sciences, complemented by extensive research experience that spans cellular studies, antimicrobial resistance, and innovative therapeutic materials. Dr. Ahmadi’s research primarily focuses on antibacterial mechanisms, carbapenem-resistant pathogens, mesenchymal stem cell applications, wound-healing biomaterials, and clinical microbiology, positioning him at the forefront of efforts to address global challenges related to drug-resistant infections. Over his career, he has authored 28 peer-reviewed publications, which have collectively attracted over 297 citations, earning him an h-index of 9, reflecting both productivity and scholarly influence. His recent works—including studies on the antibacterial potential of BM-MSCs encapsulated in collagen–fibrin hydrogels and analyses of the global prevalence of carbapenem-resistant Pseudomonas aeruginosa—demonstrate his commitment to translational research with clear clinical and societal benefits. Dr. Ahmadi has collaborated with more than 50 international co-authors, highlighting his strong interdisciplinary and cross-institutional engagement. His research has contributed to advancing knowledge in infection control, biomaterials engineering, and public health, with widespread relevance to clinicians, biomedical researchers, and health-policy stakeholders. Although primarily dedicated to research, he also supports the scientific community through peer-review activities and participation in scholarly dissemination. Dr. Ahmadi’s work continues to influence emerging strategies for combating antibiotic-resistant infections and improving therapeutic outcomes, underscoring his role as an important contributor to global scientific progress.

Profiles: Scopus | ORCID | Google Scholar | Research Gate

Featured Publications

1. Ahmadi, M. H. (2021). Global status of tetracycline resistance among clinical isolates of Vibrio cholerae: A systematic review and meta-analysis. Antimicrobial Resistance & Infection Control.

2. Farzi, S., Rezazadeh, M., Mirhosseini, A., Rezazadeh, M. A., Houshyar, F., & Ahmadi, M. H. (2021). Genetic diversity of healthcare-associated methicillin-resistant Staphylococcus aureus isolates from Southern Iran. Acta Microbiologica et Immunologica Hungarica.

3. Ahmadi, M. H. (2021). Resistance to tetracyclines among clinical isolates of Mycoplasma hominis and Ureaplasma species: A systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy.

4. Ahmadi, M. H. (2020). Indicated and non-indicated antibiotic administration during pregnancy and its effect on pregnancy outcomes: Role of inflammation. International Immunopharmacology.

5. Ahmadi, M. H. (2020). Frequency of antimicrobial resistance and class 1 and 2 integrons in Escherichia coli strains isolated from urinary tract infections. Iranian Journal of Pharmaceutical Research.